1 July 2024 v2025.80.1 micro_entity_frs_105_v1_1_3 filingSoftwarefalsetruetruetruefalseNo description of principal activity00truexbrli:purexbrli:sharesiso4217:GBP126500942024-07-012025-06-30126500942025-06-30126500942024-06-3012650094core:WithinOneYear2025-06-3012650094core:WithinOneYear2024-06-3012650094bus:RegisteredOffice2024-07-012025-06-3012650094bus:Director12024-07-012025-06-301265009412024-07-012025-06-30126500942023-07-012024-06-3012650094countries:EnglandWales2024-07-012025-06-3012650094bus:AuditExemptWithAccountantsReport2024-07-012025-06-3012650094bus:PrivateLimitedCompanyLtd2024-07-012025-06-3012650094bus:Micro-entities2024-07-012025-06-3012650094bus:FullAccounts2024-07-012025-06-30
Company registration number:
12650094
PQ CLINICAL CONSULTING LTD
Unaudited Filleted Financial Statements for the year ended
30 June 2025
PQ CLINICAL CONSULTING LTD
Statement of Financial Position
30 June 2025
20252024
££
Fixed assets
5,128
 
12,850
 
   
Current assets
66,398
 
47,504
 
Creditors: amounts falling due within one year
(6,889
)
(15,043
)
Net current assets
59,509
 
32,461
 
Total assets less current liabilities
64,637
 
45,311
 
Accruals and deferred income
(900
)
(2,194
)
Net assets
63,737
 
43,117
 
   
Capital and reserves
63,737
 
43,117
 

Notes to the Financial Statements

1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is
62 High Street
,
Hythe
,
Kent
,
CT21 5AL
, United Kingdom.

2 Average number of employees

The average number of persons employed by the company during the year was nil (2024: nil).

3 Directors' advances, credit and guarantees

As at the 30th June 2025 the balance of the directors loan account was £331 CR (2024: £11,911 CR)
For the year ending
30 June 2025
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the
board of directors
and authorised for issue on
5 December 2025
, and are signed on behalf of the board by:
Dr Paul Quinn
Director
Company registration number:
12650094